2022
Rapid Deployment of a Mobile Medical Clinic During the COVID-19 Pandemic: Assessment of Dyadic Maternal-Child Care
Rosenberg J, Sude L, Budge M, León-Martínez D, Fenick A, Altice FL, Sharifi M. Rapid Deployment of a Mobile Medical Clinic During the COVID-19 Pandemic: Assessment of Dyadic Maternal-Child Care. Maternal And Child Health Journal 2022, 26: 1762-1778. PMID: 35900640, PMCID: PMC9330972, DOI: 10.1007/s10995-022-03483-6.Peer-Reviewed Original ResearchConceptsPeople of colorHealth-related social needsQualitative interviewsSocial needsMobile medical clinicCOVID-19 pandemicMother-infant careConstant comparative methodFood insecurityService deliveryMaternal child careMajor themesInterviewsMedical clinicsFamily-centered careInsecurityComparative methodMaternal-infant careMixed-methods observational studyOffice-based visitsAssessment of caregiversInnovative modelSurvey participantsMaternal hypertensionChart review
2020
Tocilizumab Treatment for Cytokine Release Syndrome in Hospitalized Patients With Coronavirus Disease 2019 Survival and Clinical Outcomes
Price CC, Altice FL, Shyr Y, Koff A, Pischel L, Goshua G, Azar MM, Mcmanus D, Chen SC, Gleeson SE, Britto CJ, Azmy V, Kaman K, Gaston DC, Davis M, Burrello T, Harris Z, Villanueva MS, Aoun-Barakat L, Kang I, Seropian S, Chupp G, Bucala R, Kaminski N, Lee AI, LoRusso PM, Topal JE, Dela Cruz C, Malinis M. Tocilizumab Treatment for Cytokine Release Syndrome in Hospitalized Patients With Coronavirus Disease 2019 Survival and Clinical Outcomes. CHEST Journal 2020, 158: 1397-1408. PMID: 32553536, PMCID: PMC7831876, DOI: 10.1016/j.chest.2020.06.006.Peer-Reviewed Original ResearchConceptsCytokine release syndromeTocilizumab-treated patientsSevere diseaseRelease syndromeTocilizumab treatmentInflammatory biomarkersNonsevere diseaseSoluble IL-2 receptor levelsHigh-sensitivity C-reactive proteinIL-2 receptor levelsConsecutive COVID-19 patientsIL-6 receptor antagonistMechanical ventilation outcomesC-reactive proteinCOVID-19 patientsHigher admission levelsRace/ethnicityMV daysVentilation outcomesAdverse eventsChart reviewClinical responseMedian ageWhite patientsClinical outcomes
2018
The Influence of Housing Status on the HIV Continuum of Care: Results From a Multisite Study of Patient Navigation Models to Build a Medical Home for People Living With HIV Experiencing Homelessness
Rajabiun S, Tryon J, Feaster M, Pan A, McKeithan L, Fortu K, Cabral HJ, Borne D, Altice FL. The Influence of Housing Status on the HIV Continuum of Care: Results From a Multisite Study of Patient Navigation Models to Build a Medical Home for People Living With HIV Experiencing Homelessness. American Journal Of Public Health 2018, 108: s539-s545. PMID: 32941777, PMCID: PMC6290582, DOI: 10.2105/ajph.2018.304736.Peer-Reviewed Original ResearchPatient navigation modelViral suppressionHIV outcomesHousing statusCo-occurring substance useAntiretroviral therapy prescriptionHigh rateAntiretroviral therapyChart reviewHIV continuumPatient navigatorsTherapy prescriptionMedical homePsychiatric disordersSubstance useMultisite studyHIVStable housingOutcomesCareMonthsHousing stabilityInterventionStatusNetwork of services
2012
Retention on buprenorphine treatment reduces emergency department utilization, but not hospitalization, among treatment-seeking patients with opioid dependence
Schwarz R, Zelenev A, Bruce RD, Altice FL. Retention on buprenorphine treatment reduces emergency department utilization, but not hospitalization, among treatment-seeking patients with opioid dependence. Journal Of Substance Use And Addiction Treatment 2012, 43: 451-457. PMID: 22534003, PMCID: PMC3419304, DOI: 10.1016/j.jsat.2012.03.008.Peer-Reviewed Original ResearchConceptsBuprenorphine maintenance treatmentHealthcare utilizationED utilizationEmergency department usageOpioid-dependent patientsEmergency department utilizationLate-stage diseaseTreatment-seeking patientsBuprenorphine treatmentChart reviewPerson yearsED useMaintenance treatmentOpioid dependenceDependent patientsPrimary careHospitalizationDrug usersNegative binomial regressionBinomial regressionPatientsComparison of timeTreatmentAverage lengthStay
2009
Early initiation of antiretroviral therapy results in decreased morbidity and mortality among patients with TB and HIV
Tabarsi P, Saber‐Tehrani A, Baghaei P, Padyab M, Mansouri D, Amiri M, Masjedi MR, Altice FL. Early initiation of antiretroviral therapy results in decreased morbidity and mortality among patients with TB and HIV. Journal Of The International AIDS Society 2009, 12: 14-14. PMID: 19607726, PMCID: PMC2734561, DOI: 10.1186/1758-2652-12-14.Peer-Reviewed Original ResearchCells/mm3HIV/TB patientsCD4 countTB patientsTB treatmentGroup IAntiretroviral therapyEarly initiationGroup IIAntiretroviral therapy resultsHIV-infected patientsNew opportunistic infectionsActive antiretroviral therapyMasih Daneshvari HospitalRetrospective chart reviewAdverse drug reactionsInjection of drugsDrug-drug interactionsComplications of managementDrug toxicity profilesAdvanced HIVChart reviewImproved survivalRetrospective reviewOpportunistic infections
2001
Trust and the Acceptance of and Adherence to Antiretroviral Therapy
Altice F, Mostashari F, Friedland G. Trust and the Acceptance of and Adherence to Antiretroviral Therapy. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2001, 28: 47-58. DOI: 10.1097/00126334-200109010-00008.Peer-Reviewed Original ResearchInjection drug usersAntiretroviral therapyPotent new therapyStandardized chart reviewSocial isolationDrugs of abuseAntiretroviral regimenHIV clinicChart reviewHIV infectionHIV medicationsObserved therapyCorrelates of acceptanceHealth beliefsClinical informationHealth locusNew therapiesSide effectsPharmacy reviewDrug usersHealth statusInfected prisonersAIDS incidenceTherapyTherapeutic agentsTrust and the Acceptance of and Adherence to Antiretroviral Therapy.
Altice FL, Mostashari F, Friedland GH. Trust and the Acceptance of and Adherence to Antiretroviral Therapy. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2001, 28: 47. PMID: 11579277, DOI: 10.1097/00042560-200109010-00008.Peer-Reviewed Original ResearchConceptsInjection drug usersAntiretroviral therapyPotent new therapyStandardized chart reviewSocial isolationDrugs of abuseAntiretroviral regimenHIV clinicChart reviewHIV infectionHIV medicationsObserved therapyCorrelates of acceptanceHealth beliefsClinical informationHealth locusNew therapiesSide effectsPharmacy reviewDrug usersHealth statusInfected prisonersAIDS incidenceTherapyTherapeutic agents
1999
Nevirapine induced opiate withdrawal among injection drug users with HIV infection receiving methadone
Altice F, Friedland G, Cooney E. Nevirapine induced opiate withdrawal among injection drug users with HIV infection receiving methadone. AIDS 1999, 13: 957-962. PMID: 10371177, DOI: 10.1097/00002030-199905280-00012.Peer-Reviewed Original ResearchConceptsPharmacokinetic interactionsOpiate withdrawalMethadone levelsWithdrawal symptomsChronic methadone maintenance therapyNon-nucleoside reverse transcriptase inhibitorSubstance abuseInitiation of therapyMethadone maintenance therapyOpiate withdrawal symptomsRetrospective chart reviewSignificant pharmacokinetic interactionsInjection drug usersReverse transcriptase inhibitorHIV therapeutic agentsAntiretroviral therapyMaintenance therapyMethadone doseChart reviewHIV diseaseHIV infectionIncreased doseTranscriptase inhibitorTherapeutic benefitPatientsClinical Guidelines and Pharmacist Intervention Program for HIV‐Infected Patients Requiring Granulocyte Colony‐Stimulating Factor Therapy
Engles‐Horton L, Skowronski C, Mostashari F, Altice F. Clinical Guidelines and Pharmacist Intervention Program for HIV‐Infected Patients Requiring Granulocyte Colony‐Stimulating Factor Therapy. Pharmacotherapy The Journal Of Human Pharmacology And Drug Therapy 1999, 19: 356-362. PMID: 10221375, DOI: 10.1592/phco.19.4.356.30938.Peer-Reviewed Original ResearchConceptsIntervention periodPreintervention periodFactor therapyG-CSFGranulocyte colony-stimulating factor therapyHuman immunodeficiency virus (HIV) infectionColony-stimulating factor therapyPharmacist intervention programPharmacist-based interventionMean hospital stayImmunodeficiency virus infectionHospital medical information systemG-CSF dosesNumber of patientsMedical house staffTherapeutics subcommitteeHospital stayPharmacist interventionsChart reviewHospitalized patientsClinical pharmacistsImmunodeficiency syndromePatient morbidityPharmacy costsClinical guidelines